Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 2/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.45 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.38 |
| ▸ | IDH1 | O75874 | 1/20 | 0.37 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.37 |
| ▸ | KMO | O15229 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 1/20 | 0.34 |
| ▸ | SYK | P43405 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20527122 | 0.81 | CYP11B2 (0.48) | CYP11B2CYP11B1GABRA5GABRG2GABRB3 | |
| Hydrochloric Acid SCHEMBL18226990 | 0.80 | CYP11B2 (0.47) | CYP11B2CYP11B1GABRA5GABRG2GABRB3 | |
| SCHEMBL22969002 | 0.76 | MAPT (0.33) | GABRA5GABRG2GABRB3 | |
| SCHEMBL2228272 | 0.75 | CYP11B2 (0.47) | CYP11B2CYP11B1GABRA5GABRG2GABRB3 | |
| SCHEMBL30954127 | 0.72 | CYP11B2 (0.42) | CYP11B2CYP11B1GABRA5GABRG2GABRB3 | |
| SCHEMBL13178859 | 0.72 | GABRG2 (0.43) | CYP11B2CYP11B1GABRA5GABRG2GABRB3 | |
| SCHEMBL16972829 | 0.72 | CYP11B2 (0.42) | CYP11B2CYP11B1GABRA5GABRG2GABRB3 | |
| SCHEMBL31125023 | 0.71 | CYP11B2 (0.46) | CYP11B2CYP11B1PDE3BPDE3A | |
| SCHEMBL31125026 | 0.71 | CYP11B2 (0.46) | CYP11B2CYP11B1PDE3BPDE3A | |
| SCHEMBL13780087 | 0.71 | KMO (0.58) | PDE3BPDE3AIDH1KMOTERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180289718-A1 | FUSED IMIDAZOLE COMPOUNDS | ONO PHARMACEUTICAL CO., LTD. (JP) | 2018-10-11 | — | — | US | disclosed |
| US-10016439-B2 | Fused imidazole compounds | ONO PHARMACEUTICAL CO., LTD. (JP) | 2018-07-10 | — | — | US | disclosed |
| US-20160331757-A1 | FUSED IMIDAZOLE COMPOUNDS | ONO PHARMACEUTICAL CO., LTD. (JP) | 2016-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180289718-A1 | FUSED IMIDAZOLE COMPOUNDS | GABRA5, CHRNA5, GABRP | CYP11B2 209/4885CYP11B1 150/4885GABRA5 1/4885 |
| US-20160331757-A1 | FUSED IMIDAZOLE COMPOUNDS | GABRA5, CHRNA5, GABRP | CYP11B2 209/4885CYP11B1 150/4885GABRA5 1/4885 |
| US-10016439-B2 | Fused imidazole compounds | GABRA5, CHRNA5, GABRP | CYP11B2 209/4885CYP11B1 150/4885GABRA5 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.